Integral Health Asset Management, LLC Aerie Pharmaceuticals Inc Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$7.02 - $13.33 $1.76 Million - $3.33 Million	-250,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $1.81 Million - $2.66 Million	-160,000 Reduced 39.02%	250,000 $2.85 Million
Q2 2021 Aug 30, 2021	SELL	$15.16 - $18.97 $6.22 Million - $7.78 Million	-410,000 Reduced 50.0%	410,000 $6.56 Million
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $7.13 Million - $8.92 Million	470,000 Added 134.29%	820,000 $13.1 Million
Q1 2021 May 10, 2021	BUY	$13.12 - $20.9 $1.97 Million - $3.14 Million	150,000 Added 75.0%	350,000 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $1.82 Million - $2.9 Million	200,000 New	200,000 $2.7 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.